MetLife Investment Advisors LLC lifted its position in shares of Livent Corporation (NASDAQ:LTHM) by 281.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 63,109 shares of the company’s stock after acquiring an additional 46,544 shares during the quarter. MetLife Investment Advisors LLC’s holdings in Livent were worth $775,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of the company. PNC Financial Services Group Inc. acquired a new stake in Livent in the 4th quarter valued at about $31,000. Exane Derivatives acquired a new stake in shares of Livent during the 1st quarter worth approximately $32,000. First Mercantile Trust Co. acquired a new stake in shares of Livent during the 1st quarter worth approximately $33,000. Synovus Financial Corp acquired a new stake in shares of Livent during the 1st quarter worth approximately $39,000. Finally, Shell Asset Management Co. acquired a new stake in shares of Livent during the 1st quarter worth approximately $40,000.
LTHM stock traded down $0.08 during midday trading on Thursday, hitting $6.89. The company’s stock had a trading volume of 787,540 shares, compared to its average volume of 2,649,582. The firm has a 50-day moving average of $6.88. Livent Corporation has a 52-week low of $6.22 and a 52-week high of $19.90.
A number of analysts have recently issued reports on the stock. Vertical Research downgraded shares of Livent from a “buy” rating to a “hold” rating in a report on Thursday, May 9th. Zacks Investment Research downgraded shares of H&E Equipment Services from a “hold” rating to a “sell” rating in a report on Wednesday. Gabelli downgraded shares of Livent from a “buy” rating to a “sell” rating in a report on Thursday, May 9th. Loop Capital restated a “buy” rating and set a $75.00 price target on shares of Green Dot in a report on Thursday, May 9th. Finally, Argus raised their price target on shares of Leidos to $82.00 and gave the stock a “positive” rating in a report on Thursday, May 16th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $16.11.
Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.
Recommended Story: Do back-end load funds outperform no-load funds?
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.